Literature DB >> 21768855

Postpartum pharmacokinetics of peramivir in the treatment of 2009 H1N1 influenza.

Patrick G Clay1, Raghavendra B Adiga, Tracey A H Taylor, Rachael Alsup, Phillip M Gerk, MaryPeace McRae.   

Abstract

BACKGROUND: 2009 H1N1 influenza A disproportionately affected pregnant and postpartum women compared with the general population, with higher rates of hospitalization and severe illness. We present a case of the use and pharmacokinetics of intravenous peramivir in the treatment of a patient with severe influenza. CASE: A 28-year-old woman at 37 weeks of gestation presented to the hospital with severe respiratory symptoms. 2009 H1N1 influenza reverse transcriptase polymerase chain reaction returned positive results and intravenous peramivir was started. She showed rapid improvement and was discharged 29 days after admission.
CONCLUSION: The pharmacokinetic parameters in this patient were unexpected because the clearances occurred more quickly than in phase I trials. These differences highlight the need for additional pharmacokinetic reporting of peramivir in pregnant and postpartum women.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768855      PMCID: PMC3140068          DOI: 10.1097/AOG.0b013e31821b1b3e

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic.

Authors:  Sara F Goldkind; Leyla Sahin; Beverly Gallauresi
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

2.  Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma.

Authors:  N Lindegardh; W Hanpithakpong; A Phakdeeraj; P Singhasivanon; J Farrar; T T Hien; N J White; N P J Day
Journal:  J Chromatogr A       Date:  2008-11-08       Impact factor: 4.759

3.  H1N1 influenza in pregnancy: cause for concern.

Authors:  Erin Saleeby; Jocelyn Chapman; Jessica Morse; Allison Bryant
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

Review 4.  Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Authors:  Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Serial changes in renal haemodynamics during normal human pregnancy.

Authors:  W Dunlop
Journal:  Br J Obstet Gynaecol       Date:  1981-01

6.  H1N1 2009 influenza virus infection during pregnancy in the USA.

Authors:  Denise J Jamieson; Margaret A Honein; Sonja A Rasmussen; Jennifer L Williams; David L Swerdlow; Matthew S Biggerstaff; Stephen Lindstrom; Janice K Louie; Cara M Christ; Susan R Bohm; Vincent P Fonseca; Kathleen A Ritger; Daniel J Kuhles; Paula Eggers; Hollianne Bruce; Heidi A Davidson; Emily Lutterloh; Meghan L Harris; Colleen Burke; Noelle Cocoros; Lyn Finelli; Kitty F MacFarlane; Bo Shu; Sonja J Olsen
Journal:  Lancet       Date:  2009-07-28       Impact factor: 79.321

7.  Severe 2009 H1N1 influenza in pregnant and postpartum women in California.

Authors:  Janice K Louie; Meileen Acosta; Denise J Jamieson; Margaret A Honein
Journal:  N Engl J Med       Date:  2009-12-23       Impact factor: 91.245

  7 in total
  2 in total

1.  Pharmacokinetic Properties of Peramivir After Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers.

Authors:  Ming Zhang; Zhan-Zhang Wang; Xiao-Jia Ni; Li-Zhong Li; Yue-Feng Zhang; Hao-Yang Lu; Huan Peng; Wen-Can Huang; Ling-Fang Shen; Ling-Hui Xiong; De-Wei Shang; Yu-Guan Wen
Journal:  Clin Drug Investig       Date:  2016-09       Impact factor: 2.859

Review 2.  Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections.

Authors:  Malak M Alame; Elie Massaad; Hassan Zaraket
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.